Journal
VIROLOGY
Volume 566, Issue -, Pages 143-152Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.virol.2021.12.003
Keywords
Recombinant influenza virus; Live attenuated virus; M2e; Cross protection
Categories
Funding
- NIH/NIAID [AI093772, AI154656, AI147042]
Ask authors/readers for more resources
The study demonstrates that heterologous prime-boost vaccination with recombinant influenza viruses expressing extra M2e epitopes provides more effective cross protection than homologous vaccination. Additionally, aging was shown to compromise the induction of M2e and HA stalk specific IgG antibodies, suggesting significant effects on antibody responses in older mice.
Annual repeat influenza vaccination raises concerns about protective efficacy against mismatched viruses. We investigated the impact of heterologous prime-boost vaccination on inducing cross protection by designing recombinant influenza viruses with chimeric hemagglutinin (HA) carrying M2 extracellular domains (M2e-HA). Heterologous prime-boost vaccination of C57BL/6 mice with M2e-HA chimeric virus more effectively induced M2e and HA stalk specific IgG antibodies correlating with cross protection than homologous prime-boost vaccination. Induction of M2e and HA stalk specific IgG antibodies was compromised in 1-year old mice, indicating significant aging effects on priming subdominant M2e and HA stalk IgG antibody responses. This study demonstrates that a heterologous prime-boost strategy with recombinant influenza virus expressing extra M2e epitopes provides more effective cross protection than homologous vaccination.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available